PMVEMA-coated upconverting nanoparticles for upconversion-linked immunoassay of cardiac troponin

Surface engineering of upconverting nanoparticles (UCNPs) is crucial for their bioanalytical applications. Here, an antibody specific to cardiac troponin I (cTnI), an important biomarker for acute myocardial infection, was covalently immobilized on the surface of UCNPs to prepare a label for the detection of cTnI biomarker in an upconversion-linked immunoassay (ULISA). Core-shell UCNPs (NaYF4:Yb,Tm@NaYF4) were first coated with poly(methyl vinyl ether-alt-maleic acid) (PMVEMA) and then conjugated to antibodies. The morphology (size and uniformity), hydrodynamic diameter, chemical composition, and amount of coating on the of UCNPs, as well as their upconversion luminescence, colloidal stability, and leaching of Y3+ ions into the surrounding media, were determined. The developed ULISA allowed reaching a limit of detection (LOD) of 0.13 ng/ml and 0.25 ng/ ml of cTnI in plasma and serum, respectively, which represents 12-and 2-fold improvement to conventional enzyme-linked immunosorbent based on the same immunoreagents.

Automated summary

In this study, surface engineering of upconverting nanoparticles (UCNPs) was conducted to immobilize an antibody specific to cardiac troponin I (cTnI) for the detection of cTnI biomarker. The developed method demonstrated improved sensitivity and stability compared to the conventional enzyme-linked immunosorbent assay.